Let's grab coffee at EANM 2023
Schedule a meeting or connect with me on LinkedIn to discuss your upcoming radiopharmaceutical study and how PSI can help.
Steven
De Hertefelt
De Hertefelt
Senior Director Business Development
Mobile: +32 477 90 80 05
steven.dehertefelt@psi-cro.com
Focused & specialized global radiopharmaceutical CRO
We specialize in pivotal Phase 2 and 3 oncology trials with a focus on radiopharmaceutical studies. Over the past 25 years, PSI has built a network of trusted radiopharmaceutical sites and has a regulatory team who can navigate the specific challenges for approvals.
Read our latest resource
Operationalizing Radiopharmaceutical Clinical Trials: Opportunities & Challenges
Success starts with understanding the risk factors that can impact your radiopharmaceutical trial from startup through the clinical phase.
